American Society of Hematology

SHERPA: Blue

People

  1. Cancio
    Cancio
  2. Curran
    Curran
  3. Forlenza
    Forlenza
  4. Jackson
    Jackson
  5. Kernan
    Kernan
  6. Kung
    Kung
  7. O'Reilly
    O'Reilly
  8. Park
    Park
  9. Sadelain
    Sadelain
  10. Shukla
    Shukla

Groups

  1. Adult Leukemia (1)
  2. Bone Marrow Transplant (1)
  3. Center for Hematologic Malignancies (1)
  4. Department of Medicine (1)
  5. Executive Committee, Center for Hematologic Malignancies (1)
  6. GSK Faculty (1)
  7. Hematologic Malignancies Research (1)
  8. Hematologic Malignancies Service (1)
  9. Hematologic Malignancies, Division of (1)
  10. Immunology Program Faculty (1)
Search Within
  1. "Farid Boulad"
  2. "Center for Hematologic Malignancies"
  3. "Michel Sadelain"
  4. "Nancy Kernan"
  5. "Myeloma"
Formats
  1. Meeting Abstract (1)
Groups
  1. Adult Leukemia (1)
  2. Bone Marrow Transplant (1)
  3. Center for Hematologic Malignancies (1)
  4. Department of Medicine (1)
  5. Executive Committee, Center for Hematologic Malignancies (1)
  6. GSK Faculty (1)

More Groups

People
  1. Andrew Kung (1)
  2. Barbara Spitzer (1)
  3. Carolyn Jackson (1)
  4. Christopher Forlenza (1)
  5. Craig Sauter (1)
  6. Eric Smith (1)

More People

Years
  1. 2017 (1)
Publications
  1. Blood (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save